Letter to the Editor: Comment on “Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial” (Moreno and Belinchon 2022)
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Speech and Hearing,Otorhinolaryngology
Reference8 articles.
1. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents.;Chandrasekhar;Otolaryngol Head Neck Surg,2000
2. Middle ear exploration in patients with Ménière’s disease who have failed outpatient intratympanic gentamicin therapy.;Crane;Otol Neurotol,2009
3. The sustained-exposure dexamethasone formulation OTO-104 offers effective protection against cisplatin-induced hearing loss.;Fernandez;Audiol Neurootol,2016
4. Chemical perfusion of the inner ear.;Jackson;Otolaryngol Clin N Am,2002
5. Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig.;Laurell;Cancer Chemother Pharmacol,1995
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevention and treatment of cisplatin‐induced ototoxicity in adults: A systematic review;Clinical Otolaryngology;2023-10-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3